As the chair of Falcon Rappaport & Berkman LLP’s Cannabis & Psychedelics Practice Group, Andrew has extensive experience in the cannabis, psychedelic, and therapeutic industries, regularly guiding business owners through the numerous associated regulatory hurdles and helping to formulate corresponding business strategies. After spending most of his over 30 years…
View more